Logo image of EQ

EQUILLIUM INC (EQ) Stock Fundamental Analysis

USA - NASDAQ:EQ - US29446K1060 - Common Stock

1.34 USD
-0.07 (-4.96%)
Last: 10/27/2025, 1:35:54 PM
Fundamental Rating

2

EQ gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 534 industry peers in the Biotechnology industry. The financial health of EQ is average, but there are quite some concerns on its profitability. EQ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EQ had negative earnings in the past year.
In the past year EQ has reported a negative cash flow from operations.
In the past 5 years EQ always reported negative net income.
EQ had a negative operating cash flow in each of the past 5 years.
EQ Yearly Net Income VS EBIT VS OCF VS FCFEQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

EQ's Return On Assets of -162.87% is on the low side compared to the rest of the industry. EQ is outperformed by 87.27% of its industry peers.
With a Return On Equity value of -399.41%, EQ is not doing good in the industry: 75.09% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -162.87%
ROE -399.41%
ROIC N/A
ROA(3y)-45.84%
ROA(5y)-43.62%
ROE(3y)-98.95%
ROE(5y)-79.65%
ROIC(3y)N/A
ROIC(5y)N/A
EQ Yearly ROA, ROE, ROICEQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EQ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EQ Yearly Profit, Operating, Gross MarginsEQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

More info and screens

5

2. Health

2.1 Basic Checks

EQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EQ has been increased compared to 1 year ago.
EQ has more shares outstanding than it did 5 years ago.
EQ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EQ Yearly Shares OutstandingEQ Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
EQ Yearly Total Debt VS Total AssetsEQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -20.11, we must say that EQ is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of EQ (-20.11) is worse than 85.21% of its industry peers.
EQ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -20.11
ROIC/WACCN/A
WACC8.66%
EQ Yearly LT Debt VS Equity VS FCFEQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

EQ has a Current Ratio of 1.65. This is a normal value and indicates that EQ is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.65, EQ is doing worse than 79.96% of the companies in the same industry.
EQ has a Quick Ratio of 1.65. This is a normal value and indicates that EQ is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.65, EQ is doing worse than 79.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.65
EQ Yearly Current Assets VS Current LiabilitesEQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for EQ have decreased strongly by -124.00% in the last year.
Looking at the last year, EQ shows a very negative growth in Revenue. The Revenue has decreased by -61.16% in the last year.
EPS 1Y (TTM)-124%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1700%
Revenue 1Y (TTM)-61.16%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

Based on estimates for the next years, EQ will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.60% on average per year.
EQ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.98% yearly.
EPS Next Y-233.63%
EPS Next 2Y-78.94%
EPS Next 3Y-12.74%
EPS Next 5Y11.6%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y3.98%

3.3 Evolution

EQ Yearly Revenue VS EstimatesEQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2028 2029 2030 20M 40M 60M
EQ Yearly EPS VS EstimatesEQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EQ. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EQ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EQ Price Earnings VS Forward Price EarningsEQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EQ Per share dataEQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

A cheap valuation may be justified as EQ's earnings are expected to decrease with -12.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-78.94%
EPS Next 3Y-12.74%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EQ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EQUILLIUM INC

NASDAQ:EQ (10/27/2025, 1:35:54 PM)

1.34

-0.07 (-4.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)11-11 2025-11-11
Inst Owners12.01%
Inst Owner Change-0.44%
Ins Owners14.55%
Ins Owner Change0%
Market Cap82.03M
Revenue(TTM)16.55M
Net Income(TTM)-20194000
Analysts81.82
Price Target2.55 (90.3%)
Short Float %1.61%
Short Ratio0.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.24%
Min EPS beat(2)16.03%
Max EPS beat(2)30.44%
EPS beat(4)4
Avg EPS beat(4)49.09%
Min EPS beat(4)16.03%
Max EPS beat(4)100%
EPS beat(8)8
Avg EPS beat(8)55.85%
EPS beat(12)11
Avg EPS beat(12)78.81%
EPS beat(16)12
Avg EPS beat(16)58.12%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)150%
EPS NQ rev (1m)-1.17%
EPS NQ rev (3m)19.44%
EPS NY rev (1m)-4.44%
EPS NY rev (3m)12.35%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.96
P/FCF N/A
P/OCF N/A
P/B 16.23
P/tB 16.23
EV/EBITDA N/A
EPS(TTM)-0.56
EYN/A
EPS(NY)-0.74
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS0.27
BVpS0.08
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -162.87%
ROE -399.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-45.84%
ROA(5y)-43.62%
ROE(3y)-98.95%
ROE(5y)-79.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.93%
Cap/Sales 0.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.65
Altman-Z -20.11
F-Score2
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)111.69%
Cap/Depr(5y)164.16%
Cap/Sales(3y)0.71%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-124%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1700%
EPS Next Y-233.63%
EPS Next 2Y-78.94%
EPS Next 3Y-12.74%
EPS Next 5Y11.6%
Revenue 1Y (TTM)-61.16%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y3.98%
EBIT growth 1Y-110.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5021.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5019.56%
OCF growth 3YN/A
OCF growth 5YN/A

EQUILLIUM INC / EQ FAQ

Can you provide the ChartMill fundamental rating for EQUILLIUM INC?

ChartMill assigns a fundamental rating of 2 / 10 to EQ.


What is the valuation status for EQ stock?

ChartMill assigns a valuation rating of 0 / 10 to EQUILLIUM INC (EQ). This can be considered as Overvalued.


What is the profitability of EQ stock?

EQUILLIUM INC (EQ) has a profitability rating of 0 / 10.


What is the expected EPS growth for EQUILLIUM INC (EQ) stock?

The Earnings per Share (EPS) of EQUILLIUM INC (EQ) is expected to decline by -233.63% in the next year.